Ajanta Pharma [AJANTPHARM] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Ajanta Pharma Ltd.

NSE
Loading...

Dr. Reddy's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ajanta Pharma Ltd. wins in 12 metrics, Dr. Reddy's Laboratories Ltd. wins in 8 metrics, with 0 ties. Ajanta Pharma Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ajanta Pharma Ltd. Dr. Reddy's Laboratories Ltd. Better
P/E Ratio (TTM) 34.22 19.40 Dr. Reddy's Laboratories Ltd.
Price-to-Book Ratio 8.05 2.94 Dr. Reddy's Laboratories Ltd.
Debt-to-Equity Ratio 5.70 18.03 Ajanta Pharma Ltd.
PEG Ratio 1.27 -1.35 Ajanta Pharma Ltd.
EV/EBITDA 24.78 12.80 Dr. Reddy's Laboratories Ltd.
Profit Margin (TTM) 19.50% 16.36% Ajanta Pharma Ltd.
Operating Margin (TTM) 24.64% 16.42% Ajanta Pharma Ltd.
EBITDA Margin (TTM) 24.64% 16.42% Ajanta Pharma Ltd.
Return on Equity 24.28% 16.10% Ajanta Pharma Ltd.
Return on Assets (TTM) 18.35% 7.96% Ajanta Pharma Ltd.
Free Cash Flow (TTM) $8.39B $12.03B Dr. Reddy's Laboratories Ltd.
Dividend Yield 1.11% 11.59% Dr. Reddy's Laboratories Ltd.
1-Year Return 18.86% -6.39% Ajanta Pharma Ltd.
Price-to-Sales Ratio (TTM) 6.68 3.17 Dr. Reddy's Laboratories Ltd.
Enterprise Value $341.82B $1,085.11B Dr. Reddy's Laboratories Ltd.
EV/Revenue Ratio 6.57 3.14 Dr. Reddy's Laboratories Ltd.
Gross Profit Margin (TTM) 79.18% 53.63% Ajanta Pharma Ltd.
Revenue per Share (TTM) $416 $415 Ajanta Pharma Ltd.
Earnings per Share (Diluted) $81.22 $67.88 Ajanta Pharma Ltd.
Beta (Stock Volatility) 0.24 0.30 Ajanta Pharma Ltd.

Ajanta Pharma Ltd. vs Dr. Reddy's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

AJANTPHARM
DRREDDY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ajanta Pharma Ltd.-2.45%2.88%-3.87%3.40%15.61%3.95%
Dr. Reddy's Laboratories Ltd.0.32%0.31%-4.28%0.20%-0.09%2.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ajanta Pharma Ltd.18.86%113.15%141.11%212.59%11,142.37%53,882.76%
Dr. Reddy's Laboratories Ltd.-6.39%29.74%20.69%112.36%310.53%902.28%

Performance & Financial Health Analysis: Ajanta Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricAJANTPHARMDRREDDY
Market Information
Market Cap i₹347.59B₹1.10T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i95,1023,912,162
90 Day Avg. Volume i111,9362,668,229
Last Close₹3,054.40₹1,279.50
52 Week Range₹2,329.90 - ₹3,314.90₹1,148.40 - ₹1,375.90
% from 52W High-7.86%-7.01%
All-Time High₹3,485.00 (Sep 09, 2024)₹1,421.49 (Aug 19, 2024)
% from All-Time High-12.36%-9.99%
Growth Metrics
Quarterly Revenue Growth0.20%0.04%
Quarterly Earnings Growth0.18%-0.14%
Financial Health
Profit Margin (TTM) i0.20%0.16%
Operating Margin (TTM) i0.25%0.16%
Return on Equity (TTM) i0.24%0.16%
Debt to Equity (MRQ) i5.7018.03
Cash & Liquidity
Book Value per Share (MRQ)₹345.45₹447.25
Cash per Share (MRQ)₹75.24₹99.20
Operating Cash Flow (TTM) i₹12.01B₹63.11B
Levered Free Cash Flow (TTM) i₹9.20B₹13.47B
Dividends
Last 12-Month Dividend Yield i1.11%11.59%
Last 12-Month Dividend i₹28.00₹146.30

Valuation & Enterprise Metrics Analysis: Ajanta Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricAJANTPHARM (Apr 24, 2026)DRREDDY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.2219.40
Forward P/E i28.1624.12
PEG Ratio i1.27-1.35
Price to Sales (TTM) i6.683.17
Price to Book (MRQ) i8.052.94
Market Capitalization
Market Capitalization i₹347.59B₹1.10T
Enterprise Value i₹341.82B₹1.09T
Enterprise Value Metrics
Enterprise to Revenue i6.573.14
Enterprise to EBITDA i24.7812.80
Risk & Other Metrics
Beta i0.240.30
Book Value per Share (MRQ) i₹345.45₹447.25

Financial Statements Comparison: Ajanta Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAJANTPHARM (2025)DRREDDY (2025)
Revenue/Sales i45.88B325.54B
Cost of Goods Sold i11.27B135.11B
COGS % of Revenue i24.6%41.5%
Gross Profit i34.60B190.43B
Gross Margin i75.4%58.5%
Research & Development iN/A27.38B
Operating Income (EBIT) i11.28B72.01B
Operating Margin i24.6%22.1%
EBITDA i13.52B91.97B
EBITDA Margin i29.5%28.3%
Pre-Tax Income i11.89B76.78B
Pre-Tax Income % of Revenue i25.9%23.6%
Income Tax i2.69B19.54B
Income Tax % of Revenue i5.9%6.0%
Net Income (Profit) i9.20B57.25B
Profit Margin i20.1%17.6%

Balance Sheet & Liquidity Metrics

MetricAJANTPHARM (2025)DRREDDY (2025)
Cash & Equivalents i1.75B14.65B
Total Current Assets i28.43B250.11B
Total Current Assets % of Revenue i62.0%76.8%
Total Current Liabilities i9.96B130.39B
Total Current Liabilities % of Revenue i21.7%40.1%
Long-Term Debt i347.20M7.86B
Long-Term Debt % of Revenue i0.8%2.4%
Total Shareholders Equity i37.90B337.17B
Retained Earnings i36.72B315.79B
Retained Earnings % of Revenue i80.0%97.0%
Property, Plant & Equipment i17.16B0

Cash Flow Statement Comparison

MetricAJANTPHARM (2025)DRREDDY (2025)
Operating Cash Flow i12.01B64.09B
Operating Cash Flow % of Revenue i26.2%19.7%
Capital Expenditures i11.40M-26.99B
Free Cash Flow i8.39B12.03B
FCF Margin i18.3%3.7%
Debt Repayment iN/A-1.29B
Common Stock Repurchase i-3.51B-1.39B

Short Interest & Institutional Ownership Analysis

MetricAJANTPHARMDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i124.94M832.57M
Float Shares i41.98M599.15M
% Held by Insiders i66.38%29.45%
% Held by Institutions i21.82%51.84%
% Held by Public i11.80%18.71%

Dividend Analysis & Yield Comparison: Ajanta Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricAJANTPHARMDRREDDY
Last 12-Month Dividend i₹28.00₹146.30
Last 12-Month Dividend Yield i1.11%11.59%
3-Year Avg Annual Dividend i₹38.00₹49.30
3-Year Avg Dividend Yield i1.06%3.74%
3-Year Total Dividends i₹114.00₹147.90
Ex-Dividend DateNov 10, 2025Jul 10, 2025